Crispr Therapeutics Ag (CRSP)

Cash & Short-Term Investments

$2.36B

Quarterly · Period ending: · USD

CRSP logo

CRSP Cash & Short-Term Investments

Latest reported$2.36B
CRSP Quarterly Cash & Short-Term Investments ($155.96M → $2.36B)
High-resolution chart · PNG

CRSP cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
2,364,352,000
2,441,785,000
1,975,828,000
1,915,710,000
1,724,751,000
1,855,285,000
1,903,826,000
1,935,645,000
2,001,619,000
2,108,125,000
1,693,692,000
1,739,826,000
1,768,103,000
1,883,170,000
1,815,318,000
1,895,975,000
2,065,339,000
2,221,261,000
2,379,129,000
2,477,360,000
2,589,446,000
1,806,203,000
1,690,333,000
1,365,990,000
945,068,000
889,712,000
943,771,000
629,717,000
427,885,000
437,549,000
456,649,000
487,295,000
319,737,000
341,767,000
239,758,000
253,519,000
272,264,000
288,872,000
315,520,000
228,613,000
246,849,000
200,600,000
155,961,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.